B ()

Zihan Guo1, Chenchen Wang1, Xinyi Shi1

  • 1Department of Hematology and Oncology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China.

Oncology reports
|May 17, 2024
PubMed
概括

蛋白质组学通过识别分子机制和药物耐药性,为扩散性大B细胞淋巴瘤 (DLBCL) 提供了新的见解. 这种方法有助于开发向疗法,并改善DLBCL患者的预后评估.